Pfizer, BioNTech win approval for updated COVID-19 shot (PFE:NYSE)


Covid-19 Vaccine

carmengabriela

  • Pfizer (PFE) and BioNTech’s (BNTX) mRNA COVID-19 vaccine, COMIRNATY XFG, was approved by the US FDA for the 2026-27 season.
  • The shot targets the XFG variant.
  • COMIRNATY XFG is indicated for individuals five to 64 years old with at least one underlying condition that puts them at high risk for severe outcomes from the virus and for all adults 65 and older.



Source link

Sony’s newest TV finally has the HDMI upgrade we’ve been waiting years for

Kai Cenat Discovers Woman DMed Him After Meeting Couple

Leave a Reply

Your email address will not be published. Required fields are marked *